BACKGROUND: Medical treatment for breast cancer is associated with substantial toxicity and patient burden. There is less known about the impact of surgical complications. Understanding this impact could provide important information for patients when they are considering surgical options. METHODS: Between 2008 and 2009, the UK National Mastectomy and Breast Reconstruction Audit recorded surgical complications for a prospective cohort of 17,844 women treated for breast cancer at 270 hospitals; 6405 of these women were surveyed about their quality of life 18 months after surgery. Breast appearance, emotional well-being, and physical wellbeing were quantified on 0-to 100-point scales. Linear multiple regression models, controlling for a range of baseline prognostic factors, were used to compare the scores of patients who had complications with the scores of those who did not. RESULTS: The overall complication rate was 10.2%. Complications were associated with little or no impairment in women undergoing mastectomy without reconstruction or with delayed reconstruction. The association was much larger for flap-related complications suffered during immediate reconstruction. The breast-appearance scores (adjusted mean difference, -23.8; 95% confidence interval [CI], -31.0 to -16.6) and emotional well-being scores (adjusted mean difference, -14.0; 95% CI, -22.0 to -6.0) of these patients were much lower than those of any other patient group. Implant-related complications were not associated with a lower quality of life in any surgical group. CONCLUSIONS: There is a strong case for prospectively collecting flap-complication rates at the surgeon and surgical unit level and for allowing patients to access these data when they make choices about their breast cancer surgery. Cancer 2017;123:3460-7.
INTRODUCTION
After surgery, most patients experience some degree of morbidity, which can vary from minor discomfort and sleep disturbance to life-threatening hemorrhaging or infection. Unexpected morbidity is often called a complication and has been defined as "an event or occurrence that is associated with a disease or a healthcare intervention, is a departure from the desired course of events, and may cause, or be associated with, suboptimal outcome." 1 The association between surgical complications and quality of life was the subject of a 2016 systematic review. 2 It found that in two-thirds of the 50 published studies reviewed, patients who suffered surgical complications had significantly worse quality of life and other psychosocial outcomes than those who had no complications and that this effect persisted in the long term.
Intuitively, one would expect surgical morbidity to affect the quality of life of patients undergoing breast cancer surgery despite attempts to reduce its impact. For example, on average, patients who suffer skin or flap necrosis after breast reconstruction should be at higher risk for an impaired aesthetic outcome with associated harm to their emotional wellbeing, even after corrective measures such as debridement or revision surgery have been performed. Information on the extent of this impairment would move our understanding of breast-surgery complications beyond simple prevalence data and help patients and clinicians to weigh the harms and benefits of different surgical options.
To our knowledge, there are only 2 previous studies of the impact of complications on patients undergoing breast cancer surgery. The first compared 233 breastreconstruction patients who suffered a complication with 483 patients who did not. This study, which was retrospective and assessed patients at various time points after their surgery, found that aesthetic satisfaction was significantly lower among patients who had a complication. 3 The second compared 36 patients who suffered a complication after breast reconstruction with 136 patients with no complications and found no difference in clinicianrated aesthetic outcomes. 4 Both were single-center studies that excluded patients undergoing mastectomy without reconstruction, and they did not attempt to analyze the impact of different complication types. The paucity of literature may be due to methodological obstacles. The highest standard of evidence would require a large multicenter study to identify a sufficient number of patients suffering different types of complications. It would also require the use of standardized definitions of complications across all centers, information about important clinical covariates, and the prospective collection of perioperative morbidity data and patient-reported outcomes at standardized time points. All of the aforementioned are available from the UK National Mastectomy and Breast Reconstruction Audit. In this article, we use data from the audit to compare the quality of life of patients who had complications after breast cancer surgery with the quality of life of those who had no complications.
MATERIALS AND METHODS
Patients were recruited between January 1, 2008 and March 31, 2009 at all 150 English National Health Service acute hospital trusts providing acute breast cancer treatment, at 6 National Health Service acute hospitals in Wales and Scotland, and at 114 independent hospitals in England. Staff at these treatment centers prospectively recorded clinical data for women who were 16 years old or older, had a diagnosis of invasive carcinoma of the breast or ductal carcinoma in situ, and were undergoing unilateral mastectomy with or without immediate reconstruction or with primary delayed reconstruction after a previous mastectomy. Local staff were also asked to obtain written consent from eligible women to allow them to be sent follow-up questionnaires.
Because there is great variability in how different clinicians define complications, we focused on postsurgical problems that required treatment. Clinicians recorded all surgical complications requiring some form of treatment during the hospital admission. In this article, we describe 3 sets of perioperative complications that might be expected to have an impact on aesthetic outcomes at the breast-surgery site with consequent impairment of other aspects of quality of life:
1. Mastectomy-site complications occurring during a mastectomy, during a mastectomy with immediate reconstruction, or during a mastectomy with delayed breast reconstruction. These complications included wound infections requiring intravenous antibiotics or surgical debridement, wound dehiscence requiring reclosure, skin-flap necrosis requiring surgical debridement, and hematomas or seromas at the mastectomy site requiring aspiration or drainage.
2. Flap-related complications occurring during breast reconstruction. These complications included impaired flap perfusion requiring re-exploration or revision of the anastomosis, partial flap necrosis or failure requiring debridement, and total flap necrosis or failure requiring removal.
3. Implant/expander-related complications occurring during breast reconstruction. These complications included a displaced implant/expander requiring repositioning, an infected implant/expander requiring intravenous antibiotic therapy, an infected implant/expander requiring removal, and a ruptured implant/expander requiring removal.
A range of other clinical data items were recorded to account for confounding when patient groups were compared. These included details of surgical procedures, clinical risk factors, and sociodemographic characteristics.
To collect data on long-term quality-of-life outcomes, questionnaires were sent to consenting patients at their home address 18 months after surgery. The questionnaires were sent by a coordinating team of researchers that did not include the treating hospitals or clinicians once the team had confirmed each patient was still alive by cross-checking her details against mortality data held by the National Strategic Tracing Service. A prepaid envelope was enclosed to facilitate the return of the completed questionnaire. Questionnaires were marked only with a unique numeric patient identifier. Nonrespondents were sent a single reminder letter and an additional copy of the questionnaire at a 5-week interval. Each patient's questionnaire data were linked to her associated clinical data with her unique numeric identifier. The questionnaire addressed each patient's satisfaction with her breast-area appearance (4 items for mastectomy-alone patients and 16 items for reconstruction patients), emotional wellbeing (10 items), and physical well-being (16 items). The emotional well-being scale addressed issues such as confidence in a social setting, emotional health, and selfesteem. The physical well-being scale addressed issues such as back and shoulder pain, breast pain, and difficulty with sleeping. A separate scale on sexual well-being was included on an optional basis. Because nearly half of the follow-up sample (46%) declined to complete this section, the results are not reported. The scales were derived from the BREAST-Q family of outcome measures 5, 6 and were pretested with English breast cancer patients by the authors before their use to ensure that there were no issues with language, comprehension, or acceptability. Each scale ranged from 0 to 100, with higher scores representing better outcomes. We defined the minimum important difference as 0.5 of a standard deviation, which was equivalent to 10 points for each scale. 7 Copies of the questionnaires and clinical proformas are available online. 8 Linear multiple regression models were used to compare the BREAST-Q scale scores of patients who had complications and those who did not. Separate analyses were conducted for women who underwent mastectomy alone, women who underwent mastectomy with immediate reconstruction, and women who underwent mastectomy with delayed reconstruction. The analyses were also separated for each of the 3 complication sets described previously. Complications within each set were combined so that the set as a whole could be coded as either present or not present at the individual patient level. The denominator of patients varied with whether or not a particular complication was relevant to the surgical group being analyzed. For example, patients who did not have an implant were excluded from analyses that examined the impact of implant-related complications. The regression models included a range of baseline variables likely to be associated with quality of life so that the independent impact of suffering a complication could be estimated. The models were constructed with a backward stepwise process, and variables were dropped from the models if the strength of their association with an outcome was weak (P > .05). The initial variables in each model were the patient's age, socioeconomic deprivation status, 9 ethnicity (white or other ethnic group), smoking status, body mass index, diabetes status, American Society of Anesthesiologists physical status classification, 10 Eastern Cooperative Oncology Group score, 11 tumor type (invasive or ductal carcinoma in situ), ductal carcinoma in situ grade (low, intermediate, or high), and invasive carcinoma grade (well, moderately, or poorly differentiated).
All statistical tests were 2-sided, and P values less than .05 were considered to represent a statistically significant result. All statistical analyses were undertaken with Stata/MP 14.
At the time of this study, national cancer audits were exempt from obtaining research ethics approval. Approval to prospectively collect identifiable patient data for analysis and reporting was obtained from the Patient Information Advisory Group under Section 60 of the Health and Social Care Act of 2001. Informed written consent was obtained from women before they were sent follow-up questionnaires.
RESULTS
There were 18,216 eligible women registered within the inclusion period, of whom 17,844 had a complete record of any complications suffered during the perioperative period. The extent to which patients were successfully recruited to the patient-reported outcomes component of the study varied across treatment centers. Of the 18,216 patients registered in the study, 10,632 (58%) were asked to consent to receive follow-up questionnaires. In some cases, hospital staff did not ask for consent because of legitimate concerns regarding poor eyesight (n 5 27), literacy or language comprehension issues (n 5 166), or cognitive impairment (n 5 202). However, a large number of women were not approached for this element of the study because of logistical problems with consent procedures. Among those women who were asked, 8725 (82%) agreed to participate. After the further exclusion of those women who died during the follow-up period, 8536 women (98%) had an 18-month questionnaire sent to their home address; 7110 (83%) returned a completed 18-month questionnaire, and 6405 of these women successfully completed the breast-appearance scale and had a complete record of their perioperative complications.
The characteristics of the 17,844 women with complete complication data and the subsample of 6405 women with self-reported data about their breast appearance 18 months after surgery are shown in Table 1 . The samples were very similar, and this indicated that the subsample was likely to be representative of the larger cohort. The subsample was younger, healthier, and less deprived than the cohort as a whole, but the differences were small. The proportion of women undergoing breast-reconstruction surgery was higher in the subsample (35%) than the larger cohort (28%). Reassuringly, the proportion of women who suffered a perioperative complication in the subsample (9.8%) was almost identical to that recorded for the larger cohort (10.2%).
The proportion of women suffering different types of complications is shown in Table 2 for the subsample of women with complete follow-up data. The overall complication rate was 10.1% for women undergoing mastectomy with no reconstruction, 10.0% for women undergoing mastectomy with immediate reconstruction, and 7.6% for women undergoing delayed reconstruction. The most commonly recorded complication was a hematoma or seroma requiring aspiration or drainage: 9.0% of women undergoing only mastectomy suffered this complication, whereas 4.5% of women undergoing immediate reconstruction and 2.3% of women undergoing delayed reconstruction did. Flap-related complications were rare but slightly more frequent among women undergoing delayed reconstruction (5.4%) versus women undergoing immediate reconstruction (3.0%). Implant-related complications were infrequent in both groups and were recorded for 3.3% of immediate-reconstruction patients and for 1.4% of delayed-reconstruction patients.
Unadjusted and adjusted differences in 18-month breast-appearance scores between patients with and without complications are shown in Table 3 . The effect of adjusting for baseline factors was minimal. A negative difference suggests a worst breast-appearance outcome for patients who suffered complications. In the mastectomyonly group, patient-reported breast appearance was significantly worse for patients who had suffered a mastectomysite complication (adjusted mean difference, -2.7; 95% confidence interval [CI], -4.7 to -0.7), but this difference was less than the predefined minimally important difference of 10 points. A similar result was observed in the immediate-reconstruction group (adjusted mean difference, -7.5; 95% CI, -11.5 to -3.4), but there was no significant difference among delayed-reconstruction patients. Patients suffering a flap-related complication had significantly worse breast-appearance scores in the immediate-reconstruction group (adjusted mean difference, -23.8; 95% CI, -31.0 to -16.6), and this difference was much larger than the minimally important difference threshold. This finding was present when the analysis was separated for pedicled flap procedures (P < .001) and free flap procedures (P < .001). Flap-related complications were not associated with significantly lower breastappearance scores in the delayed-reconstruction group. In both the immediate-reconstruction group and the delayed-reconstruction group, implant-related complications were not associated with significantly worse breastappearance scores. A similar pattern was seen for the emotional and physical well-being scales (Tables 4 and 5 ). Mastectomysite complications were associated with small but statistically significant differences in favor of patients who had not had complications, but this effect was not seen with delayed-reconstruction patients. In the immediatereconstruction group, flap-related complications were associated with large differences in favor of those who did not have complications. This effect was not seen in the delayed-reconstruction group. In both reconstruction groups, implant-related complications had no association with emotional or physical well-being.
DISCUSSION
Surgical complications were associated with little or no impairment of the quality of life of women undergoing mastectomy without reconstruction or with delayed reconstruction. The association was much larger for women who suffered flap-related complications in the immediatereconstruction context. The breast-appearance and emotional well-being scores of these patients were much lower than those of any other patient group, including women who had a mastectomy with no reconstruction. Implantrelated complications were not associated with a lower quality of life in any surgical group. Physical well-being scores showed less of an association with complications across all groups.
The findings should be reassuring to women undergoing mastectomy with or without breast reconstruction. In contrast to the toxicities associated with medical treatments for breast cancer, which are reported as severe by 45% of patients and are associated with substantial impairment of quality of life, surgical complications are less frequent and are associated with much less harm. 12 The one area of concern is related to flap-related complications in women undergoing immediate reconstruction. This finding requires careful interpretation. The impact of complications on quality of life is a function of the outcome for both the women who suffer complications and those who do not. Flap-based reconstructions have, at the overall group level, outcomes superior to those of implant-only procedures, 13, 14 and the impact of flaprelated complications is, therefore, exacerbated because of the additional benefit that is lost when the operation fails. The role of patient expectations must also be considered. Flap-based reconstructions are more difficult to perform than implant-only procedures. They take longer to perform, and the recovery period is also longer. Women who choose this option may be trading the short-term hardship associated with recovering from the procedure for a better long-term outcome. Reconstructive complications and subsequent failure usually result in an unanticipated mastectomy for a woman expecting the outcomes of a flapbased immediate reconstruction. This may lead to profound disappointment in the small number of women affected.
There was no association between flap-related complications and quality of life in the delayed setting. This could be for 2 distinct reasons. First, the initial reference point for delayed-reconstruction patients is postmastectomy, and this lowers expectations. Second, unlike women in the immediate-reconstruction group, delayedreconstruction patients do not require adjuvant therapies, which may exacerbate the impact of a surgical complication, and are more likely to have undergone corrective secondary reconstruction after initial reconstructive complications or failure.
This study is the largest to date and has many strengths over the existing literature. Standardized definitions of complications were used, and complication data were collected prospectively to reduce the risk of measurement error. Complete complication data were collected for 98% of the eligible patients. The data on complications and quality of life were from different sources, and this reduced the risk that any observed associations were due to common method variance. The data were collected at 270 hospitals, and this increased the generalizability of the findings and reduced the risk that the results represented the unique practices of individual hospitals or surgeons. Follow-up was at 18 months; this means that the full impact of complications and any subsequent revision procedures and treatments was assessed. Our analysis provides separate answers for different surgical groups, including women who underwent mastectomy alone, a group that is often neglected by research in this area. We also provide a detailed analysis of the impact of different complication types for the first time.
The main limitation is the attrition between the baseline and follow-up. The follow-up cohort was slightly younger, healthier, and less deprived than the cohort as a whole. However, the most important baseline prognostic factor, the complication rate, was almost identical in the 2 groups. Although we adjusted for a wide range of prognostic factors and the adjusted and unadjusted differences between groups were very similar, it is still possible that the differences we observed were due to residual confounding. The analysis of implant procedures in the delayed-reconstruction context involved only 4 patients who suffered a complication. This means that we may have missed a real effect because of an underpowered statistical test. Finally, our study was limited to perioperative morbidity and did not assess the impact of complications occurring after discharge.
Our findings are consistent with the previous literature but provide a more detailed analysis of specific complications and surgical groups. The results complement previous studies on the effectiveness of different breast-reconstruction techniques: we are now able to characterize both the benefits and harms of these procedures. The main implication of our findings is that clinicians should discuss the risks associated with reconstruction procedures that use flaps to reconstruct the breast mound. Patients and clinicians should be aware that although flap procedures are, at the group level, associated with superior aesthetic outcomes, they carry a substantial risk for the small group of patients who suffer a flap-related complication in the immediate-reconstruction context. 13, 14 This risk goes beyond self-perceived aesthetic outcomes: it also extends to emotional and physical wellbeing. Because of these consequences, there is a strong case for prospectively collecting flap-complication rates at the surgeon and surgical unit level and for allowing patients to access these data when they make choices about their breast cancer surgery. We have previously shown that this can be achieved in the United Kingdom and have also outlined the main statistical constraints when comparisons are being performed. 15, 16 Women should be informed of the outcomes associated with both successful and failed reconstructive procedures along with the likelihood of reconstructive failure locally. They should also be made aware of the likely delay before any secondary reconstructive procedure can be undertaken and the risk that they will need to undergo a simple mastectomy, with its associated outcomes, if complications arise. Clinicians should continue to refine their patient and procedure selection processes and operative techniques to minimize the risk of flap-related complications in the immediate-reconstruction context.
